MarginsXMarginsX
Home › Data Desk › 13G holders

13G holders

Automated articles on 13G holders, built every day from SEC filings, prices and our own datasets.

All topics · Dilution · Offerings · Convertible notes · FDA approval · Licensing and milestone payments · At-the-market offering · Delistings · Mergers and acquisitions · Restaurants · Casinos · Foreign private issuer · Material weakness · Early-stage clinical trials · Oncology · FDA setbacks · Reverse split · Private placement (PIPE) · Warrants and inducements · Biofuels and renewable natural gas · Insider buying · Debt financing · Divestitures · Solar · Artificial intelligence · Equity line of credit · Late-stage clinical trials · Daily feature · Going-concern doubt · Week ahead · Customer concentration · Late filings · Weekly roundups · Rates and the dollar · Banking · Quarterly results · Dual-class shares · Inflation and interest rates · Share buybacks · AI data centers · Executive turnover · GPUs and accelerators · Big movers · IPO · Public offerings · SPAC · China exposure · Convertible preferred stock · Natural gas and LNG · Cryptocurrency · Bankruptcy · Tobacco and vaping · Related-party loans · Nasdaq deficiency notice · Payments and fintech · Alcoholic beverages · Oil and gas production · Delisting · Aerospace and aviation · Tariffs · Medical devices · 13G holders · Carbon and clean energy credits · Semiconductors · Cannabis · Electric vehicles · Name or ticker change · Aesthetics and dermatology · Pet products · Stablecoins · Critical minerals · Gold mining · Mineral exploration · Auditor changes · Drones · Cell and gene therapy · Defense and military · Exchange listing notices · OTC quotation · Battery energy storage · Authorized share increase · 13D stakes · Robotics · Market wrap · Dividend payments · Spin-offs · Carbon capture · Impairment charges · Firearms and ammunition · Reverse merger · Securities class actions · Generative AI · Layoffs and restructuring · Asset management and BDCs · Hydrogen and fuel cells · Joint ventures · REITs and real estate · Reverse splits · Data centers · Backlog and contracted revenue · Trucking and logistics · Agriculture · Wind power · Video games and esports · War and geopolitical risk · Insurance carriers · Medicare and Medicaid reimbursement

State Street Corp reports 5.9% of Redwire Corporation

State Street Corp filed a Schedule 13G on Nov 10, 2026, reporting 14.8 million shares of Redwire Corporation (RDW), 5.9% of the class, as of Sep 30, 2026. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

State Street Corp passes 5.0% of Recursion Pharmaceuticals Inc.

In a Schedule 13G filed Nov 10, 2026, State Street Corp reported 30.0 million shares of Recursion Pharmaceuticals Inc. (RXRX) as of Sep 30, 2026, 5.6% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

Adage Capital Management, L.P. passes 5.0% of First Tracks Biotherapeutics Inc.

In a Schedule 13G filed Nov 12, 2026, Adage Capital Management, L.P. reported 2.1 million shares of First Tracks Biotherapeutics Inc. (TRAX) as of Sep 30, 2026, 5.8% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 12, 2026)

November 14, 2026 · data as of 2026-11-12

Jane Street Group, LLC passes 5.0% of Aehr Test Systems

In a Schedule 13G filed Nov 10, 2026, Jane Street Group, LLC reported 1.7 million shares of Aehr Test Systems (AEHR) as of Nov 4, 2026, 5.1% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)

November 14, 2026 · data as of 2026-11-10

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Follow topics in MarginsX